Search PubMedSearch

PubMed · 1162416

Bacteroidosis.

Abstract

Bacteroides infection frequently complicates surgery, instrumentation, or trauma to the alimentary, upper respiratory, and female genitourinary tracts. Bacteroides sp, alone or with other organisms, also may cause infections in the ear, nose, and throat, and other tissues where defeneses are lowered. Foul-smelling pus, sinus drainage, material from an abscess or infected traumatic wound, or a blood culture made because of a suspected anaerobic complication should be subjected to anaerobic study in the laboratory. Treatment of clinical bacteroidosis consists of specific antibiotics, surgery, oxygen under pressure, and appropriate local dressings. Treatment is often more effective if at least two antibiotics are given concurrently, and antibiotic sensitivity tests are recommended to select the best combination.

Explore related subjects

Keep this discovery

Explore connections, maps & timelines

BibTeXRIS

H A Poindexter, D Washington. 1975. Bacteroidosis.. https://doi.org/10.1097/00007611-197508000-00014

Cite the original work for its findings. Save a collection to share your selection of sources.

KEEP EXPLORING

Related citations

Tazobactam is a potent inactivator of selected inhibitor-resistant class A beta-lactamases.

The beta-lactam beta-lactamase inhibitor combinations (ampicillin/clavulanate, ampicillin/sulbactam, ticarcillin/clavulanate and piperacillin/tazobactam) were tested against selected inhibitor-resistant class A beta-lactamases of the TEM and OHIO-1 varieties. Minimum inhibitor concentrations (MIC) revealed that the Escherichia coli DH5 alpha transconjugate strains that possessed the OHIO-1 beta-lactamase, Met69Ile mutant of the OHIO-1 beta-lactamase, TEM-30 (Arg244Ser) and TEM-31 (Arg244Cys) beta-lactamase were most susceptible to piperacillin and piperacillin/tazobactam. Kinetic experiments with each beta-lactamase demonstrated that tazobactam was 10-25-fold more potent than clavulanate or sulbactam against TEM-30 and TEM-31 beta-lactamase. Tazobactam was also as effective as clavulanate against the Met69Ile mutant of the OHIO-1 beta-lactamase. Among the clinically available beta-lactams and beta-lactamase inhibitors, piperacillin/tazobactam appears to be the most potent combination against selected inhibitor-resistant strains of TEM and OHIO-1 beta-lactamase.

Ampicillin

[Lyme borreliosis in dogs].

In a 2-year-old Bernese Mountain dog the diagnosis of Lyme borreliosis was made, using the criteria that are mentioned in the literature: seropositivity in the presence of the typical clinical symptoms, with infestation of ticks in the history. The usual therapy of amoxycillin or tetracyclines was inadequate and did not resolve the clinical symptoms, possibly as a result of a combination of initial corticosteroid therapy, the clinical presentation of the disease (mainly meningitis), and a presumed immuno-incompetence often seen in this breed. Intravenous treatment with amoxycillin finally led to total cure of the disease. Lyme borreliosis recurred half a year later, presumably as a result of a new tick infestation. A review of the literature on Lyme borreliosis in humans and dogs is presented. The fact that Lyme borreliosis in dogs in the Netherlands has not been diagnosed often and has not been reported before may be due to differences in approach to human and canine patients with fever.

Ampicillin